Making considered changes that will deliver benefits in the longer-term, regardless of any short- term disruption or pain, calls for...
SpliceBio CEO: The Route From US Academic To Spanish Gene Tech Entrepreneur
Startup Co-founder And CEO Explains The Difficult Process Of ‘Rolling Down The Sleeves’ And Allowing Strategic Activity To Take Precedence
From an early stage in his career, Miquel Vila-Perelló saw himself as a research academic. It was an ambition he duly fulfilled. Later, seeing the greater potential to bring benefit to human health by forming his own company, he co-founded SpliceBio, a Spain-based startup focusing on gene therapies for rare diseases.

More from Business Strategy
More from In Vivo
• By
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
• By
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.